| Financial Year |
March 31 2021 |
| Monetary Funds |
120,512,334.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
630,958.36 |
| Accounts Receivable |
250,775,805.30 |
| Advances to Suppliers |
9,018,214.38 |
| Other Receivables |
10,707,380.84 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
159,924,363.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
16,105,500.88 |
| Total Current Assets |
582,266,831.27 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
13,463,650.24 |
| Investment Properties |
20,959,323.81 |
| Fixed Assetes |
553,841,007.46 |
| Under-construction Projects |
26,013,608.78 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,832,583.22 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
16,076,822.30 |
| Deferred Income Tax Assets |
7,911,479.50 |
| Other Non-Current Assets |
176,776,432.52 |
| Sub-Total of Non-Current Assets |
846,874,907.83 |
| Total Assets |
1,429,141,739.10 |
| Short-Term Loans |
264,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
134,890,078.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,256,075.22 |
| Taxes Payable |
10,188,218.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
89,682,689.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
770,533.56 |
| Sub-Total of Current Liabilities |
523,973,385.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,485,611.22 |
| Total Liabilities |
568,458,996.63 |
| Paid-In Capital(Or Share Stock) |
173,303,798.00 |
| Capital Surplus |
386,762,916.01 |
| Surplus Reserve |
30,010,733.16 |
| LESS:Treasury Stock |
31,162,200.00 |
| Undistributed Profits |
290,160,382.20 |
| Minority Stockholder's Interest |
11,607,113.10 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
849,075,629.37 |
| Owner's Equity（Stockholder's Equity） |
860,682,742.47 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,429,141,739.10 |
